Smoking and mental illness

Pharmacology Biochemistry and Behavior

Volumn 70, Issue 4, 2001, Pages 561-570

  Leonard, S ^a,b   Adler, L E ^a,b   Benhammou, K ^a   Berger, R ^a   Breese, C R ^c   Drebing, C ^a   Gault, J ^a   Lee, M J ^a   Logel, J ^a   Olincy, A ^a,b   Ross, R G ^a,b   Stevens, K ^a,b   Sullivan, B ^a   Vianzon, R ^a   Virnich, D E ^a   Waldo, M ^a,b   Walton, K ^a   Freedman, R ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c AUBURN UNIVERSITY   (United States)

Author keywords

Bipolar disorder; Genetic linkage; Mental illness; Neuroleptic; Nicotine addiction; Nicotine binding; Nicotinic acetylcholine receptors; Schizophrenia; Sensory deficit; Smoking; 7 subunit

Indexed keywords

NICOTINIC RECEPTOR; RECEPTOR SUBUNIT; TRITIUM;

ARTICLE; ATTENTION DEFICIT DISORDER; AUTOPSY; CHROMOSOME 15; DEPRESSION; DRUG RECEPTOR BINDING; GENE LOCUS; GENETIC DISORDER; GENETIC LINKAGE; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; SCHIZOPHRENIA; SENSORY DYSFUNCTION; SMOKING; SMOKING CESSATION;

ANIMALIA; NICOTIANA TABACUM;

EID: 0035708459     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00677-3     Document Type: Review

References (139)

1. Relationship between up-regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation
2. Neurophysiological studies of sensory gating in rats: Effects of amphetamine, phencyclidine, and haloperidol
3. Sensory physiology and catecholamines in schizophrenia and mania
4. 10 Years of studies on P50 sensory gating - A review and considerations for future studies
5. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics
6. Normalization of auditory physiology by cigarette smoking in schizophrenic patients
7. Schizophrenia, sensory gating, and nicotinic receptors
8. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist
9. Neuronal nicotinic acetylcholine receptor activation modulates gamma-aminobutyric acid release from CA1 neurons of rat hippocampal slices
10. The opioid antagonist naltrexone inhibits activity and alters expression of alpha 7 and alpha 4 beta 2 nicotinic receptors in hippocampal neurons: Implications for smoking cessation programs
11. Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines
12. Cigarette smoking among adults - United States, 1997
13. Neurophysiological assessment of sensory gating in psychiatric inpatients: Comparison between schizophrenia and other diagnoses
14. Sensitization of the mesoaccumbens dopamine response to nicotine
15. Genetics of schizophrenia and the new millennium: Progress and pitfalls
16. 3H]Nicotine binding in peripheral blood cells of smokers is correlated with the number of cigarettes smoked per day
17. Non-nicotine pharmacotherapy for smoking cessation - Mechanisms and prospects
18. 3H]nicotine binding sites in human brain
19. Auditory sensory gating in hippocampal neurons: A model system in the rat
20. Development of major depressive disorder during smoking-cessation treatment
21. 125I]-α-bungarotoxin binding in human postmortem brain
22. 3H]nicotine binding in human postmortem brain
23. Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia
24. Impaired startle prepulse inhibition and habituation in patients with schizoptypal personality-disorder
25. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: Evidence of inhibitory deficits
26. Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
27. Is eye movement dysfunction a biological marker for schizophrenia? A methodological review
28. P50 suppression among schizophrenia and normal comparison subjects: A methodological analysis
29. Poor P50 suppression among schizophrenia patients and their first-degree biological relatives
30. Impaired attention as an endophenotype for molecular genetic studies of schizophrenia
31. Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: Alpha-bungarotoxin and nicotine binding in the thalamus
32. Major depression following smoking cessation
33. Chromosome workshop: Chromosomes 11, 14, and 15
34. No evidence for linkage between schizophrenia and markers at chromosome 15q13-14
35. Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings
36. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia
37. Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex
38. Characterisation of the binding of [H-3]methyllycaconitine: A new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors
39. GABA immunoreactivity in the thalamic reticular nucleus of the rat. A light and electron microscopical study
40. Role of dopamine in the behavioural actions of nicotine related to addiction
41. Expression of the human α7 neuronal nicotinic acetylcholine receptor and a partial gene duplication
42. Antipsychotic regulation of dopamine D1, D2 and D3 receptor mRNA
43. Human post-mortem striatal alpha 4 beta 2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome
44. Initial genomic scan of the NIMH genetics initiative bipolar pedigrees: Chromosomes 3, 5, 15, 16, 17, and 22
45. Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire
46. Positron emission tomographic analysis of central D1-dopamine and D2-dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine - Relation to extrapyramidal side-effects
47. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter
48. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration
49. The relationship between tobacco use and mental disorders
50. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: Comparison of medicated and drug-free patients
51. Candidate for inherited neurobiological dysfunction in schizophrenia
52. Elementary neuronal dysfunctions in schizophrenia
53. α-Bungarotoxin binding to hippocampal interneurons: Immunocytochemical characterization and effects on growth factor expression
54. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia
55. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
56. Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha 7-nicotinic acetylcholine receptor subunit gene (CHRNA7)
57. Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function
58. Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine
59. The effect of clozapine on the speed and accuracy of information processing in schizophrenia
60. Genomic organization and partial duplication of the human α7 neuronal nicotinic acetylcholine receptor gene
61. Mutation analysis of the α7 nicotinic acetylcholine receptor gene and its partial duplication in schizophrenia patients
62. Comorbidity of psychiatric and substance abuse disorders
63. Effects of clozapine on smoking in chronic schizophrenic outpatients
64. Cigarette smoking: Implications for psychiatric illness
65. Psychiatry and cigarettes
66. Smoking, smoking cessation, and major depression
67. Cigarette smoking, major depression, and schizophrenia
68. Negative effects of a smoking ban on an inpatient psychiatry service
69. Nicotinic receptor desensitization and sensory gating deficits in schizophrenia
70. Smooth pursuit ocular motor dysfunction in schizophrenia: Evidence for a major gene
71. Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain
72. Glutamate and GABA release are enhanced by different subtypes of presynaptic nicotinic receptors in the lateral geniculate nucleus
73. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking
74. Nicotinic receptor activation modulates GABA release from neurons in human cortical slices
75. Bupropion - A review of its use in the management of smoking cessation
76. Smooth pursuit eye movements in psychopathology
77. Eye movement dysfunctions and psychosis
78. Pursuit eye movement dysfunctions in schizophrenia. Family evidence for specificity
79. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine-D(1) receptors
80. NIMH Genetics Initiative Millenium Schizophrenia Consortium: Linkage analysis of African-American pedigrees
81. The effect of nicotine and haloperidol co-treatment on nicotinic receptor levels in the rat brain
82. Attention and memory impairment in schizophrenia: A longitudinal study of drug naive patients
83. The role of nicotine and nicotinic receptors in psychopathology
84. Nicotinic receptors, smoking and schizophrenia
85. Further investigation of a chromosome 15 locus in schizophrenia: Analysis of affected sibpairs from the NIMH Genetics Initiative
86. Smoking and schizophrenia: Abnormal nicotinic receptor expression
87. Chronic haloperidol administration does not block acute nicotine-induced improvements in radial-arm maze performance in the rat
88. Development of nicotinic drug therapy for cognitive disorders
89. Nicotinic acetylcholine involvement in cognitive function in animals
90. Transdermal nicotine effects on attention
91. Social interaction and sensorimotor gating abnormalities in mice lacking Dvll
92. Functional contribution of neuronal AChR subunits revealed by antisense oligonucleotides
93. Suggestive evidence for linkage of schizophrenia to markers at chromosome 15q13-14 in Taiwanese families
94. Event-related potentials in a working-memory task in schizophrenics and controls
95. Cholinergic gating of response to auditory stimuli in rat hippocampus
96. Presynaptic ionotropic receptors and the control of transmitter release
97. A dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains
98. Variation of nicotinic binding sites among inbred strains
99. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
100. Clozapine decreases drive to smoke
101. Clozapine decreases smoking in patients with chronic schizophrenia
102. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia
103. Genetic analysis of nicotine-induced seizures and hippocampal nicotinic receptors in the mouse
104. Nicotine enhances sustained attention in the rat under specific task conditions
105. New views of the thalamic reticular nucleus in the adult and the developing brain
106. Gating of auditory P50 in schizophrenics: Unique effects of clozaphine
107. No evidence for linkage of the CHRNA7 gene region in Canadian schizophrenia families
108. Differential effects of acute and chronic nicotine on dopamine output in the core and shell of the rat nucleus accumbens
109. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers
110. Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients
111. Mice deficient in the alpha 7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents
112. Clozapine-induced acetylcholine release in the rat prefrontal cortex, nucleus accumbens and striatum does not develop tolerance
113. Alpha 7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: A behavioral characterization of Acra7-deficient mice
114. Increased nicotinic receptors in brains from smokers: Membrane binding and autoradiography studies
115. A randomized trial of nortriptyline for smoking cessation
116. A quantitative analysis of saccades and smooth pursuit during visual pursuit tracking. A comparison of schizophrenics with normals and substance abusing controls
117. Cognitive effects of nicotine
118. Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families
119. Reduction in auditory gating following intracerebroventricular application of α-bungarotoxin binding site ligands and α7 antisense oligonucleotides
120. Anticipatory saccades during smooth pursuit eye movements and familial transmission of schizophrenia
121. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors
122. Molecular cloning, functional properties, and distribution of rat brain α7: A nicotinic cation channel highly permeable to calcium
123. Effects of typical and atypical antipsychotic drugs on acetylcholine release in the hippocampus
124. Schizophrenia and smoking: Evidence for a common neurobiological basis?
125. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains
126. Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice
127. Splitting schizophrenia: Periodic catatonia-susceptibility locus on chromosome 15q15
128. Genetic linkage of the CHRNA7 region on chromosome 15 to schizophrenia in a large Veterans Affairs cooperative study sample
129. A genome scan using a pharmacogenetic approach indicates a susceptibility locus for BD on 15q14
130. Input dysfunction in schizophrenia
131. Codistribution of a sensory gating deficit and schizophrenia in multi-affected families
132. Familial transmission of risk factors in the first-degree relatives of schizophrenic people
133. The biological basis of schizophrenia: New directions
134. Presynaptic nicotinic ACh receptors
135. Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families